Pulse Biosciences, Inc. (NASDAQ:PLSE) reported Q4 EPS of ($0.52), $0.01 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $844 thousand versus the consensus estimate of $870 thousand.
For earnings history and earnings-related data on Pulse Biosciences, Inc., click here.